Patents by Inventor Paul Robert Rosteck

Paul Robert Rosteck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lp mammalian proteins; related reagents
    Publication number: 20040152885
    Abstract: Isolated nucleic acid molecules encoding polypeptides from a human, reagents related thereto (including purified polypeptides specific antibodies) are provided. Methods of using said reagents and diagnostic kits are also provided.
    Type: Application
    Filed: August 27, 2003
    Publication date: August 5, 2004
    Inventors: Bernard Yaovi Amegadzie, Margaret Barbara Basinski, William L. Scott, Dayue Chen, Chongxi Huang, Gerald Patrick Keleher, Douglas Raymond Perkins, Paul Robert Rosteck, Scott William Rowlinson, Patanjali Raghavac Sankhavaram, Eugene Thomas Seno, Eric Wen Su, Yu Zhi
  • HUMAN PREOPTIC REGULATORY FACTOR-2 AND USES THEREOF
    Publication number: 20030120039
    Abstract: The present invention relates to novel hPORF-2 polypepiides, including isolated nucleic acids that encode hPORF-2 polypeptides, vectors, host cells, transgenics, chimerics, and hPORF-2-specific antibodies, as well as methods of making and using such.
    Type: Application
    Filed: May 6, 2002
    Publication date: June 26, 2003
    Inventors: Xuan Mei Li, Paul Robert Rosteck, Eric Wen Su, He Wang, Jian-Jun Wei
  • SAM operon
    Publication number: 20030022322
    Abstract: The invention provides isolated nucleic acid compounds encoding a novel SAM synthetase of Streptomyces fradiae. Also provided are vectors and transformed heterologous host cells for expressing the SAM synthetase and a method for preparing S-adenosylmethionine from recombinant host cells transformed with the SAM synthetase gene.
    Type: Application
    Filed: August 31, 2001
    Publication date: January 30, 2003
    Inventors: Bradley Stuart DeHoff, Paul Robert Rosteck
  • Streptococcus pneumoniae gene sequence FtsZ
    Patent number: 6350866
    Abstract: The invention provides isolated nucleic acid compounds encoding FtsZ of Streptococcus pneumoniae. Also provided are vectors and transformed host cells for expressing the encoded protein, and a method for identifying compounds that bind and/or inhibit said protein.
    Type: Grant
    Filed: December 8, 1997
    Date of Patent: February 26, 2002
    Assignee: Eli Lilly and Company
    Inventors: Paul Luther Skatrud, Robert Brown Peery, Q May Wang, Paul Robert Rosteck, Jr., Pamela Kay Rockey
  • SAM operon
    Patent number: 6312920
    Abstract: The invention provides isolated nucleic acid compounds encoding a novel SAM synthetase of Streptomyces fradiae. Also provided are vectors and transformed heterologous host cells for expressing the SAM synthetase and a method for preparing S-adenosylmethionine from recombinant host cells transformed with the SAM synthetase gene.
    Type: Grant
    Filed: October 22, 1997
    Date of Patent: November 6, 2001
    Assignee: Eli Lilly and Company
    Inventors: Bradley Stuart DeHoff, Paul Robert Rosteck, Jr.
  • Muri protein from Streptococcus pneumoniae
    Patent number: 6171834
    Abstract: The invention provides isolated nucleic acid compounds encoding the stem peptide biosynthetic gene murI of Streptococcus pneumoniae. Also provided are vectors and transformed heterologous host cells for expressing the MurI enzyme product and a method for identifying compounds that inhibit stem peptide biosynthesis.
    Type: Grant
    Filed: April 30, 1999
    Date of Patent: January 9, 2001
    Assignee: Eli Lilly and Company
    Inventors: Jo Ann Hoskins, Franklin Harpold Norris, Pamela Kay Rockey, Paul Robert Rosteck, Jr., Paul Luther Skatrud, Patti Jean Treadway, Michele Louise Young Bellido, Chyun-Yeh Earnest Wu
  • Streptococcus pneumoniae gene sequence dnaG
    Patent number: 6162617
    Abstract: The invention provides isolated nucleic acid compounds encoding dnaG of Streptococcus pneumoniae. Also provided are vectors and transformed host cells for expressing the encoded protein, and a method for identifying compounds that bind and/or inhibit said protein.
    Type: Grant
    Filed: December 8, 1997
    Date of Patent: December 19, 2000
    Assignee: Eli Lilly and Company
    Inventors: Stanley Gene Burgett, Jo Ann Hoskins, Stanley Richard Jaskunas, Jr., Robert Brown Peery, Paul Robert Rosteck, Jr., Genshi Zhao
  • Streptococcus pneumoniae gene sequence FtsY
    Patent number: 5958730
    Abstract: The invention provides isolated nucleic acid compounds encoding FtsY of Streptococcus pneumoniae. Also provided are vectors and transformed host cells for expressing the encoded protein, and a method for identifying compounds that bind and/or inhibit said protein.
    Type: Grant
    Filed: December 8, 1997
    Date of Patent: September 28, 1999
    Assignee: Eli Lilly and Company
    Inventors: Paul Luther Skatrud, Robert Brown Peery, Q May Wang, Paul Robert Rosteck, Jr., Michele Louise Young Bellido
  • Biosynthetic gene muri from Streptococcus pneumoniae
    Patent number: 5948645
    Abstract: The invention provides isolated nucleic acid compounds encoding the stem peptide biosynthetic gene murI of Streptococcus pneumoniae. Also provided are vectors and transformed heterologous host cells for expressing the MurI enzyme product and a method for identifying compounds that inhibit stem peptide biosynthesis.
    Type: Grant
    Filed: December 4, 1996
    Date of Patent: September 7, 1999
    Assignee: Eli Lilly and Company
    Inventors: Jo Ann Hoskins, Franklin Harpold Norris, Pamela Kay Rockey, Paul Robert Rosteck, Jr., Paul Luther Skatrud, Patti Jean Treadway, Michele Louise Young Bellido, Chyun-Yeh Earnest Wu